• IGFBP2-THBS1 Axis: Mechanism of GH-Induced Bone Growth in IS

  2026-05-06

  This study elucidates how growth hormone (GH) therapy promotes bone growth in idiopathic short stature (ISS) children by activating the IGF-1 pathway through IGFBP2-mediated inhibition of THBS1. The findings uncover a critical regulatory axis, offering new mechanistic insight and a potential therapeutic target for enhancing GH treatment efficacy in ISS.

• IPA-3: Precision Pak1 Autophosphorylation Inhibition in Rese

  2026-05-06

  IPA-3, a non-ATP-competitive Pak1 inhibitor, offers unmatched selectivity for dissecting Pak1-driven signaling in cancer and neuroinflammation studies. This article translates bench research and recent virology findings into practical workflows, troubleshooting tips, and comparative insights for experimentalists.

• BMS-345541: IKK-1/IKK-2 Inhibitor for Inflammation & Cancer

  2026-05-05

  BMS-345541, a selective IKK-1/IKK-2 inhibitor, empowers researchers with unprecedented control over NF-κB signaling, enabling precise dissection of inflammation and apoptosis pathways. This guide details robust workflows, highlights advanced use-cases, and provides troubleshooting strategies for maximized experimental reproducibility.

• Anti Reverse Cap Analog: Enhancing mRNA Capping Efficiency

  2026-05-05

  Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, revolutionizes synthetic mRNA workflows by ensuring orientation-specific capping for superior translational efficiency. Its use empowers mRNA therapeutics, gene editing, and neurological research with reproducible, high-yield protein expression.

• Catalpol Modulates Neuroinflammation in Sepsis-Associated En

  2026-05-04

  This study demonstrates that catalpol, a natural iridoid glycoside, alleviates cognitive impairment in a mouse model of septic-associated encephalopathy (SAE) by inhibiting NF-κB-driven neuroinflammation and activating TrkB-mediated BDNF signaling. These findings clarify catalpol’s dual mechanism of action and highlight its translational relevance for neuroprotection research.

• Tankyrase Inhibition Suppresses HCC via Hippo Pathway Modula

  2026-05-04

  Jia et al. (2017) demonstrated that tankyrase 1/2 inhibition, including with G007-LK, suppresses hepatocellular carcinoma (HCC) cell proliferation by destabilizing YAP through Hippo pathway activation. This work clarifies a mechanistic link between tankyrase inhibition, YAP downregulation, and potential therapeutic strategies in HCC.

• Technical Guide: HyperScribe™ T7 High Yield Cy3 RNA Labeling

  2026-05-03

  The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus provides a reproducible workflow for generating high-yield, Cy3-labeled RNA probes for applications such as in situ hybridization and Northern blot assays. It is intended strictly for research use and is not validated for diagnostic or therapeutic workflows.

• Decoding Cy3 RNA Probe Precision with HyperScribe™ T7 Kit

  2026-05-02

  Explore how the HyperScribe T7 High Yield Cy3 RNA Labeling Kit achieves unprecedented control in fluorescent RNA probe generation. This article uniquely connects technical optimization with practical insights from the latest biomarker research.

• Thiothixene: Typical Antipsychotic Agent for Efferocytosis W

  2026-05-02

  Thiothixene stands apart as both a robust typical antipsychotic agent and a uniquely potent enhancer of in vitro macrophage efferocytosis. This article details protocol-driven strategies, troubleshooting insights, and advanced applications that harness APExBIO’s high-quality Thiothixene for reproducible neuroimmune research.

• Repurposing Natural Compounds to Inhibit SARS-CoV-2 Proteins

  2026-05-01

  Eskandari et al. (2022) used molecular docking and dynamics to identify vitamins and natural compounds that bind key residues of the SARS-CoV-2 main protease (3CLpro) and spike protein RBD, proposing these as accessible candidates for antiviral research. Their computational approach supports the utility of repurposing safe, low-cost molecules to disrupt viral entry and replication, highlighting mechanistic targets relevant for COVID-19 therapeutics.

• 2X HyperFusion High-Fidelity Master Mix in Precision Cloning

  2026-04-30

  2X HyperFusion High-Fidelity Master Mix streamlines high-accuracy DNA amplification for cloning and CRISPR workflows. Its advanced proofreading polymerase enables robust, low-error PCR even with complex templates—empowering researchers to achieve reproducible, publication-grade results with minimal optimization.

• Berberine Hydrochloride in Gut-Immune Modulation and Metabol

  2026-04-30

  Explore the multifaceted roles of berberine hydrochloride in gut-immune regulation, metabolic research, and novel assay development. This article delivers an advanced perspective on its mechanisms, practical application, and protocol optimization for researchers.

• Pam3CSK4 TFA: Optimizing TLR1/2 Agonist Workflows in Immunol

  2026-04-29

  Pam3CSK4 TFA stands out as a high-purity, synthetic TLR1/2 agonist for dissecting innate immune responses in both in vitro and in vivo models. This guide translates bench research into actionable protocols, with troubleshooting tips for robust cytokine profiling and applications in maternal-neonatal immunity.

• 3X (DYKDDDDK) Peptide: Precision Tool for Lipid Regulation S

  2026-04-29

  Discover how the 3X (DYKDDDDK) Peptide enables high-sensitivity protein detection and affinity purification in ER lipid regulation research. This in-depth analysis reveals advanced assay strategies and integrates the latest mechanistic insights for molecular biologists.

• Tris(2-carboxyethyl) Phosphine Hydrochloride: Reducing Agent

  2026-04-28

  Tris(2-carboxyethyl) phosphine hydrochloride (TCEP hydrochloride) is a water-soluble, thiol-free reducing agent that enables robust disulfide bond reduction in biochemical assays. Its stability, selectivity, and compatibility with protein analysis have made it widely adopted for protein digestion enhancement and advanced redox workflows.

450 records 19/30 page Previous Next First page 上5页 1617181920 下5页 Last page